Alar Pharmaceuticals Statistics

Total Valuation

TPEX:6785 has a market cap or net worth of TWD 11.82 billion. The enterprise value is 9.47 billion.

Market Cap	11.82B
Enterprise Value	9.47B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	Jun 10, 2025

Share Statistics

TPEX:6785 has 66.80 million shares outstanding. The number of shares has increased by 8.55% in one year.

Current Share Class	66.80M
Shares Outstanding	66.80M
Shares Change (YoY)	+8.55%
Shares Change (QoQ)	-1.27%
Owned by Insiders (%)	24.57%
Owned by Institutions (%)	4.97%
Float	36.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,672.36
PB Ratio	4.83
P/TBV Ratio	4.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-541.29
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-189.70

Financial Position

The company has a current ratio of 32.17, with a Debt / Equity ratio of 0.00.

Current Ratio	32.17
Quick Ratio	31.71
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-1,961.56

Financial Efficiency

Return on equity (ROE) is -0.71% and return on invested capital (ROIC) is -2.14%.

Return on Equity (ROE)	-0.71%
Return on Assets (ROA)	-2.08%
Return on Invested Capital (ROIC)	-2.14%
Return on Capital Employed (ROCE)	-3.44%
Revenue Per Employee	261,852
Profits Per Employee	-647,704
Employee Count	27
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-13.67M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.85% in the last 52 weeks. The beta is 0.11, so TPEX:6785's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-5.85%
50-Day Moving Average	150.76
200-Day Moving Average	145.16
Relative Strength Index (RSI)	67.12
Average Volume (20 Days)	274,389

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6785 had revenue of TWD 7.07 million and -17.49 million in losses. Loss per share was -0.27.

Revenue	7.07M
Gross Profit	4.69M
Operating Income	-84.35M
Pretax Income	-31.16M
Net Income	-17.49M
EBITDA	-81.76M
EBIT	-84.35M
Loss Per Share	-0.27

Full Income Statement

Balance Sheet

The company has 2.36 billion in cash and 2.46 million in debt, giving a net cash position of 2.36 billion or 35.29 per share.

Cash & Cash Equivalents	2.36B
Total Debt	2.46M
Net Cash	2.36B
Net Cash Per Share	35.29
Equity (Book Value)	2.45B
Book Value Per Share	37.12
Working Capital	2.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.39 million and capital expenditures -30.51 million, giving a free cash flow of -49.90 million.

Operating Cash Flow	-19.39M
Capital Expenditures	-30.51M
Free Cash Flow	-49.90M
FCF Per Share	-0.75

Full Cash Flow Statement

Margins

Gross margin is 66.38%, with operating and profit margins of -1,193.03% and -247.36%.

Gross Margin	66.38%
Operating Margin	-1,193.03%
Pretax Margin	-440.72%
Profit Margin	-247.36%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.14%.

Dividend Per Share	0.25
Dividend Yield	0.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-8.55%
Shareholder Yield	-8.41%
Earnings Yield	-0.15%
FCF Yield	-0.42%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6785 has an Altman Z-Score of 84.72.

Altman Z-Score	84.72
Piotroski F-Score	n/a